Healthcare provider profile · identity verified

John L Genier, M.D.

Internal Medicine · FAIRPORT, NY · NPI 1811931900

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	881	263
Losartan Potassium	Losartan Potassium	578	167
Amlodipine Besylate	Amlodipine Besylate	560	150
Omeprazole	Omeprazole	434	131
Lisinopril	Lisinopril	427	114
Levothyroxine Sodium	Levothyroxine Sodium	409	109
Hydrochlorothiazide	Hydrochlorothiazide	344	96
Metoprolol Succinate	Metoprolol Succinate	343	98
Gabapentin	Gabapentin	325	74
Rosuvastatin Calcium	Rosuvastatin Calcium	242	77
Sertraline Hcl	Sertraline Hcl	218	61
Eliquis	Apixaban	193	44
Simvastatin	Simvastatin	184	51
Famotidine	Famotidine	178	59
Valsartan	Valsartan	170	49
Meloxicam	Meloxicam	160	52
Trazodone Hcl	Trazodone Hcl	154	48
Pantoprazole Sodium	Pantoprazole Sodium	142	38
Metformin Hcl	Metformin Hcl	133	40
Tamsulosin Hcl	Tamsulosin Hcl	127	44
Albuterol Sulfate Hfa	Albuterol Sulfate	126	59
Furosemide	Furosemide	106	39
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	105	20
Fluticasone Propionate	Fluticasone Propionate	103	33
Potassium Chloride	Potassium Chloride	103	35
Alprazolam	Alprazolam	102	40
Escitalopram Oxalate	Escitalopram Oxalate	101	34
Metoprolol Tartrate	Metoprolol Tartrate	97	26
Zolpidem Tartrate	Zolpidem Tartrate	90	13
Allopurinol	Allopurinol	88	23
Duloxetine Hcl	Duloxetine Hcl	81	19
Alendronate Sodium	Alendronate Sodium	79	23
Atenolol	Atenolol	79	22
Prednisone	Prednisone	78	48
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	75	18
Citalopram Hbr	Citalopram Hydrobromide	72	21
Celecoxib	Celecoxib	71	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	20
Labetalol Hcl	Labetalol Hcl	70	18
Fluoxetine Hcl	Fluoxetine Hcl	68	22
Oxycodone Hcl	Oxycodone Hcl	66	19
Synthroid	Levothyroxine Sodium	64	17
Tramadol Hcl	Tramadol Hcl	62	27
Carvedilol	Carvedilol	61	18
Ozempic	Semaglutide	61	12
Chlorthalidone	Chlorthalidone	55	19
Azithromycin	Azithromycin	53	44
Montelukast Sodium	Montelukast Sodium	53	17
Irbesartan	Irbesartan	51	14
Bupropion Hcl Sr	Bupropion Hcl	50	13
Pravastatin Sodium	Pravastatin Sodium	50	13
Pregabalin	Pregabalin	49	11
Valacyclovir	Valacyclovir Hcl	47	16
Cephalexin	Cephalexin	43	37
Jardiance	Empagliflozin	42	suppressed
Ezetimibe	Ezetimibe	41	11
Bupropion Xl	Bupropion Hcl	40	12
Acetaminophen-Codeine	Acetaminophen With Codeine	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	28
Gemfibrozil	Gemfibrozil	33	suppressed
Metformin Hcl Er	Metformin Hcl	32	12
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	16
Diazepam	Diazepam	31	15
Felodipine Er	Felodipine	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Torsemide	Torsemide	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Amoxicillin	Amoxicillin	26	22
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Glipizide	Glipizide	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	21
Colchicine	Colchicine	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Spironolactone	Spironolactone	25	11
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Finasteride	Finasteride	24	suppressed
Lorazepam	Lorazepam	23	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Ramipril	Ramipril	22	suppressed
Xarelto	Rivaroxaban	21	suppressed
Estradiol	Estradiol	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Eszopiclone	Eszopiclone	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Nystatin	Nystatin	15	12
Trospium Chloride	Trospium Chloride	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Paroxetine Cr	Paroxetine Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error